These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5789512)

  • 1. Oxyphenbutazone-induced parotitis.
    Gross L
    Ann Intern Med; 1969 Jun; 70(6):1229-30. PubMed ID: 5789512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parotitis due to oxyphenylbutazone therapy].
    Eliakim R; Stalnikowicz R
    Harefuah; 1981 Dec; 101(12):361-2. PubMed ID: 7341379
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced parotitis.
    Thompson DF
    J Clin Pharm Ther; 1993 Aug; 18(4):255-8. PubMed ID: 7901230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puzzles in practice. Parotitis.
    Mishriki YY
    Postgrad Med; 2013 Mar; 125(2):158-60. PubMed ID: 23977711
    [No Abstract]   [Full Text] [Related]  

  • 5. Parotitis Following Routine Use of Sodium Deoxycholate for Jowl Contouring.
    Law G; Burgess S; Carruthers JDA
    Dermatol Surg; 2021 Mar; 47(3):425-427. PubMed ID: 32826604
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxyphenbutazone-induced goitre.
    Lane RJ; Clark F; McCollum JK
    Postgrad Med J; 1977 Feb; 53(616):93-5. PubMed ID: 141661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parotitis due to ritodrine tocolytic treatment for preterm labor.
    Marioni G; Marchese-Ragona R; Ottaviano G; Campobasso C; Staffieri A
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):665-6. PubMed ID: 15806068
    [No Abstract]   [Full Text] [Related]  

  • 8. Oxyphenbutazone-induced sialadenitis.
    Chen JH; Ottolenghi P; Distenfeld A
    JAMA; 1977 Sep; 238(13):1399. PubMed ID: 578199
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oxyphenbutazone-induced hyperkalemia in selective hypoaldosteronism in adults].
    Merkt J
    Dtsch Med Wochenschr; 1983 Oct; 108(40):1535-6. PubMed ID: 6617511
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute parotitis after injection of poly-L-lactic acid for malar augmentation: a case report and review of relevant anatomy.
    Nichols BJ; Carpenter J; Hribar KP; Go J; Rice DH
    Dermatol Surg; 2011 Mar; 37(3):381-6. PubMed ID: 21352404
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary adverse effects of oxyphenbutazone].
    Lakartidningen; 1977 May; 74(21):2109. PubMed ID: 865186
    [No Abstract]   [Full Text] [Related]  

  • 12. A review and assessment of drug-induced parotitis.
    Brooks KG; Thompson DF
    Ann Pharmacother; 2012 Dec; 46(12):1688-99. PubMed ID: 23249870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrofurantoin-induced parotitis.
    Meyboom RH; van Gent A; Zinkstok DJ
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):1049. PubMed ID: 6812739
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.
    Wadman B; Werner I
    Lancet; 1967 Mar; 1(7490):597-8. PubMed ID: 4163976
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
    Inman WH
    Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine).
    Krook G
    Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxyphenbutazone (Tanderil) and blood dyscrasia.
    Brownlie BE; Strang PJ
    N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
    [No Abstract]   [Full Text] [Related]  

  • 18. Uncommon manifestation of organophosphorus poisoning.
    Lohiya R; Sangle S
    J Postgrad Med; 2011; 57(3):224-5. PubMed ID: 21941065
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular sarcoidosis.
    James DG; Neville E; Langley DA
    Trans Ophthalmol Soc U K (1962); 1976 Apr; 96(1):133-9. PubMed ID: 1070842
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: diffuse pulmonary disorder caused by oxyphenbutazone.
    Cameron DC
    Br Med J; 1975 May; 2(5969):500-1. PubMed ID: 1148675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.